Chugai Pharmaceutical Co., Ltd. CHGCF
OTC PK
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | ||
|---|---|---|---|---|---|
| Net Income | -- | 16.09% | -55.15% | -40.96% | |
| Total Depreciation and Amortization | -- | 0.39% | -8.59% | -7.14% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | -40.86% | -195.04% | -68.42% | |
| Change in Net Operating Assets | -- | -3.24% | 1,322.90% | 323.78% | |
| Cash from Operations | -- | -12.83% | -2.17% | 41.26% | |
| Capital Expenditure | -- | -54.19% | 12.40% | -12.64% | |
| Sale of Property, Plant, and Equipment | -- | 1,193.23% | -59.46% | -58.53% | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | 26.24% | 98.33% | -9.09% | |
| Cash from Investing | -- | 12.00% | 72.52% | -17.68% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -1.42% | 298.27% | -- | |
| Issuance of Common Stock | -- | -15.48% | -27.72% | 28.21% | |
| Repurchase of Common Stock | -- | 40.00% | 63.64% | 12.50% | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -124.21% | -124.27% | -19.57% | |
| Other Financing Activities | -- | -5.29% | -99.32% | -49.43% | |
| Cash from Financing | -- | -117.97% | -117.31% | -18.40% | |
| Foreign Exchange rate Adjustments | -- | 346.64% | 918.72% | -123.85% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -1,200.00% | 153.49% | |
| Net Change in Cash | -- | -232.66% | -29.97% | 229.10% | |